Mysteries of Type I IFN response: benefits versus detriments

Successful containment of an infection is dependent on both innate and adaptive immune response. Cytokines are essential effectors of both of these systems. In particular, type I interferons (IFN-I) are important components of early innate immunity against an infection. However, the production of IF...

Full description

Saved in:
Bibliographic Details
Superior document:Frontiers Research Topics
:
Year of Publication:2015
Language:English
Series:Frontiers Research Topics
Physical Description:1 electronic resource (74 p.)
Tags: Add Tag
No Tags, Be the first to tag this record!
id 993543633504498
ctrlnum (CKB)3710000000824729
(oapen)https://directory.doabooks.org/handle/20.500.12854/54188
(EXLCZ)993710000000824729
collection bib_alma
record_format marc
spelling Herbert Patrick Ludewick auth
Mysteries of Type I IFN response: benefits versus detriments
Mysteries of Type I IFN response
Frontiers Media SA 2015
1 electronic resource (74 p.)
text txt rdacontent
computer c rdamedia
online resource cr rdacarrier
Frontiers Research Topics
Successful containment of an infection is dependent on both innate and adaptive immune response. Cytokines are essential effectors of both of these systems. In particular, type I interferons (IFN-I) are important components of early innate immunity against an infection. However, the production of IFN-I could serve as a double edge sword, either containing an infection or enhancing susceptibility. For example, IFN-I, which is essential for early containment of viral infections, has been shown to be detrimental to the host during bacterial infections. In fact, recent significant reports have shown that influenza virus induced IFN-I responses can enhance the host susceptibility to secondary bacterial infections. These recent reports highlight the expanding immunoregulatory role of IFN-I in the host immunity. With these recent findings in mind, the aim of this research topic is to welcome novel data, opinion and literature reviews on the newly identified dual functions of IFN-I. This research topic wills focus on the following areas of IFN-I: 1) a detrimental role of IFN-I during primary bacterial infection; 2) a detrimental role of viral infection induced IFN-I during secondary bacterial infections; 3) evolutionary pressure that drove detrimental IFN-I response during primary bacterial infection; and 4) does benefit of IFN-I responses during primary viral infections outweigh the adverse consequences of IFN-I mediated enhanced susceptibility to secondary bacterial infections.
English
Autoimmunity
adjuvant
bacterial and viral infections
Vaccine
type I IFN
2-88919-629-1
Arno Mullbacher auth
Yoichi Furuya auth
language English
format eBook
author Herbert Patrick Ludewick
spellingShingle Herbert Patrick Ludewick
Mysteries of Type I IFN response: benefits versus detriments
Frontiers Research Topics
author_facet Herbert Patrick Ludewick
Arno Mullbacher
Yoichi Furuya
author_variant h p l hpl
author2 Arno Mullbacher
Yoichi Furuya
author2_variant a m am
y f yf
author_sort Herbert Patrick Ludewick
title Mysteries of Type I IFN response: benefits versus detriments
title_full Mysteries of Type I IFN response: benefits versus detriments
title_fullStr Mysteries of Type I IFN response: benefits versus detriments
title_full_unstemmed Mysteries of Type I IFN response: benefits versus detriments
title_auth Mysteries of Type I IFN response: benefits versus detriments
title_alt Mysteries of Type I IFN response
title_new Mysteries of Type I IFN response: benefits versus detriments
title_sort mysteries of type i ifn response: benefits versus detriments
series Frontiers Research Topics
series2 Frontiers Research Topics
publisher Frontiers Media SA
publishDate 2015
physical 1 electronic resource (74 p.)
isbn 2-88919-629-1
illustrated Not Illustrated
work_keys_str_mv AT herbertpatrickludewick mysteriesoftypeiifnresponsebenefitsversusdetriments
AT arnomullbacher mysteriesoftypeiifnresponsebenefitsversusdetriments
AT yoichifuruya mysteriesoftypeiifnresponsebenefitsversusdetriments
AT herbertpatrickludewick mysteriesoftypeiifnresponse
AT arnomullbacher mysteriesoftypeiifnresponse
AT yoichifuruya mysteriesoftypeiifnresponse
status_str n
ids_txt_mv (CKB)3710000000824729
(oapen)https://directory.doabooks.org/handle/20.500.12854/54188
(EXLCZ)993710000000824729
carrierType_str_mv cr
hierarchy_parent_title Frontiers Research Topics
is_hierarchy_title Mysteries of Type I IFN response: benefits versus detriments
container_title Frontiers Research Topics
author2_original_writing_str_mv noLinkedField
noLinkedField
_version_ 1796652272336240640
fullrecord <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02575nam-a2200361z--4500</leader><controlfield tag="001">993543633504498</controlfield><controlfield tag="005">20231214132818.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr|mn|---annan</controlfield><controlfield tag="008">202102s2015 xx |||||o ||| 0|eng d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CKB)3710000000824729</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(oapen)https://directory.doabooks.org/handle/20.500.12854/54188</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(EXLCZ)993710000000824729</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Herbert Patrick Ludewick</subfield><subfield code="4">auth</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Mysteries of Type I IFN response: benefits versus detriments</subfield></datafield><datafield tag="246" ind1=" " ind2=" "><subfield code="a">Mysteries of Type I IFN response</subfield></datafield><datafield tag="260" ind1=" " ind2=" "><subfield code="b">Frontiers Media SA</subfield><subfield code="c">2015</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 electronic resource (74 p.)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">Frontiers Research Topics</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Successful containment of an infection is dependent on both innate and adaptive immune response. Cytokines are essential effectors of both of these systems. In particular, type I interferons (IFN-I) are important components of early innate immunity against an infection. However, the production of IFN-I could serve as a double edge sword, either containing an infection or enhancing susceptibility. For example, IFN-I, which is essential for early containment of viral infections, has been shown to be detrimental to the host during bacterial infections. In fact, recent significant reports have shown that influenza virus induced IFN-I responses can enhance the host susceptibility to secondary bacterial infections. These recent reports highlight the expanding immunoregulatory role of IFN-I in the host immunity. With these recent findings in mind, the aim of this research topic is to welcome novel data, opinion and literature reviews on the newly identified dual functions of IFN-I. This research topic wills focus on the following areas of IFN-I: 1) a detrimental role of IFN-I during primary bacterial infection; 2) a detrimental role of viral infection induced IFN-I during secondary bacterial infections; 3) evolutionary pressure that drove detrimental IFN-I response during primary bacterial infection; and 4) does benefit of IFN-I responses during primary viral infections outweigh the adverse consequences of IFN-I mediated enhanced susceptibility to secondary bacterial infections.</subfield></datafield><datafield tag="546" ind1=" " ind2=" "><subfield code="a">English</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Autoimmunity</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">adjuvant</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">bacterial and viral infections</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Vaccine</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">type I IFN</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">2-88919-629-1</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Arno Mullbacher</subfield><subfield code="4">auth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Yoichi Furuya</subfield><subfield code="4">auth</subfield></datafield><datafield tag="906" ind1=" " ind2=" "><subfield code="a">BOOK</subfield></datafield><datafield tag="ADM" ind1=" " ind2=" "><subfield code="b">2023-12-15 05:31:31 Europe/Vienna</subfield><subfield code="f">system</subfield><subfield code="c">marc21</subfield><subfield code="a">2016-08-13 16:41:26 Europe/Vienna</subfield><subfield code="g">false</subfield></datafield><datafield tag="AVE" ind1=" " ind2=" "><subfield code="i">DOAB Directory of Open Access Books</subfield><subfield code="P">DOAB Directory of Open Access Books</subfield><subfield code="x">https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&amp;portfolio_pid=5337452590004498&amp;Force_direct=true</subfield><subfield code="Z">5337452590004498</subfield><subfield code="b">Available</subfield><subfield code="8">5337452590004498</subfield></datafield></record></collection>